Loading...
Loading...
AZN| Name | Value |
|---|---|
| Revenues | 12.7B |
| Cost of Revenue | 2.2B |
| Gross Profit | 10.5B |
| Operating Expense | 7.3B |
| Operating I/L | 3.1B |
| Other Income/Expense | -0.3B |
| Interest Income | 0.1B |
| Pretax | 2.8B |
| Income Tax Expense | 0.6B |
| Net Income/Loss | 2.2B |
AstraZeneca PLC is a biopharmaceutical company specializing in the discovery, development, manufacturing, and commercialization of prescription medicines. The company's portfolio includes a range of products for oncology, cardiovascular, renal, metabolism diseases, respiratory, immunology, rare diseases, and vaccines, including treatments for COVID-19. AstraZeneca serves primary care and specialty care physicians globally through its distribution network. The company also engages in collaboration agreements with other pharmaceutical companies for the research, development, and commercialization of various medicines, demonstrating its commitment to innovation and growth in the biopharmaceutical industry.
